pubmed-article:7944932 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C0175677 | lld:lifeskim |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C0011065 | lld:lifeskim |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C0021745 | lld:lifeskim |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
pubmed-article:7944932 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:7944932 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:7944932 | pubmed:dateCreated | 1994-10-26 | lld:pubmed |
pubmed-article:7944932 | pubmed:abstractText | To assess the efficacy of interferon gamma in reducing infection and death in patients sustaining severe injury. | lld:pubmed |
pubmed-article:7944932 | pubmed:language | eng | lld:pubmed |
pubmed-article:7944932 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7944932 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:7944932 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7944932 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7944932 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7944932 | pubmed:month | Oct | lld:pubmed |
pubmed-article:7944932 | pubmed:issn | 0004-0010 | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:ChampionH RHR | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:HullR NRN | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:WeigeltJ AJA | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:LewisF RFR | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:MaierR VRV | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:ClemmerT PTP | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:JurkovichG... | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:DriesD JDJ | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:StanfordG GGG | lld:pubmed |
pubmed-article:7944932 | pubmed:author | pubmed-author:StruveS NSN | lld:pubmed |
pubmed-article:7944932 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7944932 | pubmed:volume | 129 | lld:pubmed |
pubmed-article:7944932 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7944932 | pubmed:authorsComplete | N | lld:pubmed |
pubmed-article:7944932 | pubmed:pagination | 1031-41; discussion 1042 | lld:pubmed |
pubmed-article:7944932 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:meshHeading | pubmed-meshheading:7944932-... | lld:pubmed |
pubmed-article:7944932 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7944932 | pubmed:articleTitle | Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. | lld:pubmed |
pubmed-article:7944932 | pubmed:affiliation | Department of Surgery and Shock Trauma Institute, Loyola University Medical Center, Maywood, Ill. | lld:pubmed |
pubmed-article:7944932 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7944932 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7944932 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:7944932 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:7944932 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7944932 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7944932 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7944932 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7944932 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7944932 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7944932 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7944932 | lld:pubmed |